News - Page 52 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023

Post published:May 26, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Post published:May 25, 2023
Post category:Press Release

Read more about the article Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

Post published:May 25, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical Trial Evaluating CMND-100 in Patients with Alcohol Use Disorder

Post published:May 22, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Post published:May 19, 2023
Post category:Press Release

Read more about the article Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Post published:May 19, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM GABON

FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM GABON

Post published:May 17, 2023
Post category:Press Release

Read more about the article Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

Post published:May 17, 2023
Post category:Press Release

Read more about the article Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Post published:May 17, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Post published:May 13, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.